After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
ISRO AzaadiSat: ISRO will launch AzadiSat next week, 750 girl students made this satellite
ISRO AzaadiSat Update: To mark the 75th anniversary of independence, AzadiSat, which is being pre
What is North Korea going to do? Kim Jong Un is making nuclear weapons more modern
Countries around the world keep their eyes on Kim Jong, the dictator of North Korea, almost all t
Senior Congress leader Rahul Gandhi visited a workshop of motorcycle mechanics in Delhi's Karol B
Shah Rukh Khan has received the National Film Award for the film 'Jawaan'. This is the first time
The third match of the five-Test series between India and England will be played in Rajkot from T
H-1B Visa: America gets enough applications for 2022, the limit of 65000 H-1B visas is fixed
Giving information, a US federal agency said that enough applications have been received to reach
Bollywood actress Sonakshi Sinha and Zaheer Iqbal are making headlines these days for their marri
Trouble for the makers of Dhurandhar, Major Mohit Sharma's family approaches Delhi High Court
Directed by Aditya Dhar, Dhurandhar's film is just seven days away from release. The film has bee
After PM Narendra Modi's meeting with the all-party delegation that returned from abroad, Congres
Arvind Kejriwal: Kejriwal will not resign from the post of Chief Minister, said big thing about BJP
Delhi Chief Minister Arvind Kejriwal asked why he had not tendered his resignation while in jail.
